A solution for melasma and pigmentation

Explore the range

Target pigmentation at the source

See the evidence

The problem

Why it returns after treatment

Facials, peels and laser act on pigment that has already surfaced.

None of them slow what the melanocyte does next. Hydroquinone and corticosteroids carry their own risk of thinning and rebound.

1.5–33% Estimated prevalence of melasma, with the condition most prevalent in Asian skin.

Evidence

Tested and certified.

Independent testing supports the formula’s non-irritancy and safety profile.

112.18% Certified non-irritant SGS MTT tissue viability test, December 2024.

7/7 Safety tests passed All OECD safety tests passed. No adverse classification.

ND No heavy metals detected BIO SYNERGY Laboratories, October 2024.

Zero No hydroquinone, retinoids or corticosteroids A deliberately narrow formula story.

The mechanism

Work at the source not the surface. Less made. Less passed on.

Phthalide inhibits tyrosinase.

Less melanin is produced.

Niacinamide limits transfer to keratinocytes.

Less reaches the surface.

The range

Correct. Maintain. Restore.

Three focused steps for pigmentation care. All three are water-based and fragrance-free.

Correct · 30ml

Advance Corrective Serum

For active melasma, hormonal pigmentation, sun spots and post-acne marks. Run as a course, morning and evening.

Maintain · 30ml

Daily Defense Serum

Holds the result once correction is done, and stops new marks settling in.

Restore · 30g

Radiance Moisturizing Cream

Barrier support and hydration. Carries Phthalide through the moisturising step.

Before & after

Results

Move the slider to compare the before and after images.

After image showing smoother, more even-looking skin

Before image showing visible facial pigmentation

Before After

Formulated by

Dr. Winnie Wang

PhD in Organic Chemistry, National University of Singapore.

Her background is medicinal chemistry — designing peptides, small molecules, PROTACs and RNA therapeutics.

Her drug discovery experience spans Novartis, A*STAR EDDC and Cargene Therapeutics: work where a compound has to be potent and safe, and where neither is assumed without data.

Cleradol came out of applying that discipline to a skin concern cosmetic science had mostly worked around rather than through.

01 PhD

Organic Chemistry, NUS

02 15+

Years in drug discovery

03 20+

Small-molecule patents & publications

Designed to stay simple.

Fragrance-free

Daily-use format

Three focused products

Correction into maintenance

Get in touch

Questions about Cleradol?

Contact our team for product, clinic or general enquiries.